Hans Joachim Scherer: an under-recognized pioneer of glioma research in Belgium.

Glioblastoma; Glioma; Scherer’s figures; {"lastName":"Scherer","firstNames":"Hans Joachim"}; Belgium; Brain Neoplasms/history; Germany; Glioma/history; History, 20th Century; Humans; Pathologists/history; World War II; Brain Neoplasms; Pathologists; Neurology (clinical); General Medicine

Abstract :

[en] Hans Joachim Scherer (1906-1946) was a German pathologist who fled Germany to Belgium to work on glioma genesis, growth and progression. Despite being seldom cited, and due to the contributions discussed in this article, Hans Joachim Scherer, can be considered a founding father of contemporary neuropathology and glioma research. We discuss Scherer's achievements in glioma classification, glomerular structures of glioma, primary and secondary glioblastoma, glioma growth patterns, non-resectability of glioma, pseudopalisadic necrosis and the late occurrence of symptoms in glioma.

Disciplines :

Surgery
Neurology
Oncology

Author, co-author :

REUTER, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurochirurgie

LOMBARD, Arnaud ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurochirurgie

Suero Molina, Eric; Department of Neurosurgery, University Hospital of Münster, Munster, Germany

Scholtes, Félix ; Université de Liège - ULiège > GIGA > GIGA Neurosciences - Nervous system disorders and therapy ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurochirurgie

BIANCHI, Elettra ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'anatomie et cytologie pathologiques

Language :

English

Title :

Hans Joachim Scherer: an under-recognized pioneer of glioma research in Belgium.

Publication date :

August 2021

Journal title :

Acta Neurologica Belgica

ISSN :

0300-9009

eISSN :

2240-2993

Publisher :

Springer Science and Business Media Deutschland GmbH, Italy

Volume :

121

Issue :

Pages :

867-872

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://link.springer.com/content/pdf/10.1007/s13760-021-01708-z.pdf

Funding text :

We wish to thank Mr. Marc Scherer, the son of H.J. Scherer, for his fantastic biographical and bibliographical cooperation. We also thank Pr. Pierre Maquet for his kind review and the Belgian Fondation contre le Cancer for their cooperation.

Available on ORBi :

since 13 June 2022

Statistics

Number of views

155 (5 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Burns J (1800) Dissertation on inflammation (quoted after Virchow)
Abernethy (1804) Surgical observations (quoted after Virchow)
Scherer HJ (1940) A critical review: the pathology of cerebral gliomas. J Neurol Neurosurg Psychiatry 3(2):147–177. 10.1136/jnnp.3.2.147 DOI: 10.1136/jnnp.3.2.147
Stoyanov GS, Petkova L, Dzhenkov DL (2019) Hans Joachim Scherer and his impact on the diagnostic, clinical, and modern research aspects of glial tumors. Cureus 11(11):e6148. 10.7759/cureus.6148 DOI: 10.7759/cureus.6148
Virchow R (1863) Die Lehre von den Geschwülsten, Berlin
Tooth HH (1912) Some observations on the growth and survival-period of intracranial tumours, based on the records of 500 cases, with special reference to the pathology of the gliomata. Brain 35:61–108 DOI: 10.1093/brain/35.2.61
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. 10.1007/s00401-016-1545-1 DOI: 10.1007/s00401-016-1545-1
Ferguson S, Lesniak MS (2005) Percival Bailey and the classification of brain tumors. Neurosurg Focus 18(4):e7. 10.3171/foc.2005.18.4.8 DOI: 10.3171/foc.2005.18.4.8
Eisenhardt L, Cushing H (1930) Diagnosis of intracranial tumors by supravital technique. Am J Pathol 6(5):541–552
Scherer M (2013) Some comments on the paper: Hans-Joachim Scherer (1906–1945), pioneer in glioma research. Brain Pathol 23(4):485–487. 10.1111/bpa.12066 DOI: 10.1111/bpa.12066
Scherer HJ (1941) Psychiatrische en Neurologische Bladen 45:718–738
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research N (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110. 10.1016/j.ccr.2009.12.020 DOI: 10.1016/j.ccr.2009.12.020
Scherer HJ (1933) Die Bedeutung des Mesenchyms in Gliomen. Virchows Arch 291:321–340 DOI: 10.1007/BF01996662
Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52(11):3213–3219
Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59(4):520–529. 10.1002/ijc.2910590415 DOI: 10.1002/ijc.2910590415
Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15(19):6002–6007. 10.1158/1078-0432.CCR-09-0715 DOI: 10.1158/1078-0432.CCR-09-0715
Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19(4):764–772. 10.1158/1078-0432.CCR-12-3002 DOI: 10.1158/1078-0432.CCR-12-3002
Scherer HJ (1936) Etude sur les gliomes. IV. Croissance des gliomes dans leurs rapports avec les substances blanches et grises du cerveau. Bull Assoc Franç Etude du Cancer 25:451–469
Scherer HJ (1937) Sur le développement des structures dans les gliomes. Deuxième Congrès International de Lutte Scientifique et Sociale Contre le Cancer 2:250–254
Armento A, Ehlers J, Schotterl S, Naumann U (2017) Molecular mechanisms of glioma cell motility. In: De Vleeschouwer S (ed) Glioblastoma. Codon Publications, Brisbane. 10.15586/codon.glioblastoma.2017.ch5 DOI: 10.15586/codon.glioblastoma.2017.ch5
Bougnaud S, Golebiewska A, Oudin A, Keunen O, Harter PN, Mader L, Azuaje F, Fritah S, Stieber D, Kaoma T, Vallar L, Brons NH, Daubon T, Miletic H, Sundstrom T, Herold-Mende C, Mittelbronn M, Bjerkvig R, Niclou SP (2016) Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget 7(22):31955–31971. 10.18632/oncotarget.7454 DOI: 10.18632/oncotarget.7454
Alfonso JCL, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, Hatzikirou H, Deutsch A (2017) The biology and mathematical modelling of glioma invasion: a review. J R Soc Interface. 10.1098/rsif.2017.0490 DOI: 10.1098/rsif.2017.0490
Gritsenko PG, Ilina O, Friedl P (2012) Interstitial guidance of cancer invasion. J Pathol 226(2):185–199. 10.1002/path.3031 DOI: 10.1002/path.3031
Scherer HJ (1938) Structural development in gliomas. Am J Cancer 34:333–351
Price SJ, Jena R, Burnet NG, Carpenter TA, Pickard JD, Gillard JH (2007) Predicting patterns of glioma recurrence using diffusion tensor imaging. Eur Radiol 17(7):1675–1684. 10.1007/s00330-006-0561-2 DOI: 10.1007/s00330-006-0561-2
Reuter G, Lommers E, Balteau E, Simon J, Phillips C, Scholtes F, Martin D, Lombard A, Maquet P (2020) Multiparameter quantitative histological MRI values in high-grade gliomas: a potential biomarker of tumor progression. Neuro-Oncol Pract. 10.1093/nop/npaa047 DOI: 10.1093/nop/npaa047
Scherer HJ (1936) Etude sur les gliomes. V. Comportement des différents gliomes vis-à-vis des cellules ganglionaires. Bull Assoc Franç Etude du Cancer 25:470–493
Dandy WE (1928) Removal of right cerebral hemisphere for certain tumors with hemiplegia: preliminary report. J Am Med Assoc 90(11):823–825. 10.1001/jama.1928.02690380007003 DOI: 10.1001/jama.1928.02690380007003
Scherer HJ (1940) The forms of growth in gliomas and their practical significance. Brain 63(1):1–35. 10.1093/brain/63.1.1 DOI: 10.1093/brain/63.1.1
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, Watts C, Oberg I, Pilkington G, Baumert BG, Taphoorn MJB, Hegi M, Westphal M, Reifenberger G, Soffietti R, Wick W, European Association for Neuro-Oncology Task Force on G (2017) European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol 18(6):e315–e329. 10.1016/S1470-2045(17)30194-8 DOI: 10.1016/S1470-2045(17)30194-8
Walshe F (1939). From the editor of “Brain”, 56 Portland Place W1 London
Scherer HJ (1941) Quelques résultats pratiques de l´étude complète de 135 cas de gliomes confrontés avec les expériences neuro-chirurgicales. Psychiatrische en Neurologische Bladen 45:718–738
Kleihues P, Cavenee W (2000) Pathology and genetics of tumors of the nervous system. IARC press, Lyon
Wippold FJ 2nd, Lammle M, Anatelli F, Lennerz J, Perry A (2006) Neuropathology for the neuroradiologist: palisades and pseudopalisades. AJNR Am J Neuroradiol 27(10):2037–2041
Duffau H, Mandonnet E (2013) The “onco-functional balance” in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir (Wien) 155(6):951–957. 10.1007/s00701-013-1653-9 DOI: 10.1007/s00701-013-1653-9
Oliveira AI, Anjo SI, Vieira de Castro J, Serra SC, Salgado AJ, Manadas B, Costa BM (2017) Crosstalk between glial and glioblastoma cells triggers the “go-or-grow” phenotype of tumor cells. Cell Commun Signal 15(1):37. 10.1186/s12964-017-0194-x DOI: 10.1186/s12964-017-0194-x
Kathagen-Buhmann A, Schulte A, Weller J, Holz M, Herold-Mende C, Glass R, Lamszus K (2016) Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation. Neuro Oncol 18(9):1219–1229. 10.1093/neuonc/now024 DOI: 10.1093/neuonc/now024
Lombard A, Goffart N, Rogister B (2015) Glioblastoma circulating cells: reality, trap or illusion? Stem Cells Int 2015:182985. 10.1155/2015/182985 DOI: 10.1155/2015/182985
http://www.bornbunge.be/History/Scherer.shtml. Accessed 10 Oct 2020